![]()
|
Report Date : |
22.05.2008 |
IDENTIFICATION
DETAILS
|
Name : |
DAVOS CHEMICAL, CORP. |
|
|
|
|
Registered Office : |
600 E Cresent Ave Suite 206 Upper Saddle River, NJ 07458 |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
02.10.1972 |
|
|
|
|
Legal Form : |
Corporation for Profit |
|
|
|
|
Line of Business : |
Provider of Chemical
Products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
|
REQUIRED CREDIT |
ADVISED CREDIT |
|
MAXIMUM |
150,000 USD |
|
POLITICAL DATA |
ECONOMIC DATA |
||
|
FORM OF GOVERNMENT ECONOMIC RISK |
Federal
|
CURRENCY BRANCH SITUATION |
USD 100 = EUR 64 Satisfying |
|
Company Name: |
Davos Chemical, Corp. |
||
|
Address: |
600 E Cresent Ave Suite 206 Upper Saddle River, NJ 07458 USA |
||
|
Phone: Facsimile: ID: State: Managers: |
+1 201-995-0070 +1 201-995-0071 3419117200 New Jersey Herbert Barry Robins,
President |
Date founded: |
Oct 2,1972
Corporation for Profit N.A. Employees 15 |
|
Legal form: |
|||
|
Stock: Staff: |
|||
|
|
|||
|
Business: |
Provider of chemical products. |
||
-
PCN Bank
Operations:
At the above address, we find the headquarters of the company Davos
Chemical, Corp.
The company also has offices in California, North Carolina, Italy, and
Tokyo.
Activity:
Davos Chemical, Corp is a provider of custom manufacturing services and
product to the pharmaceutical industry, particularly the emerging biotechs.
The company provides custom chemistry (complex raw materials, regulatory
intermediates & APIs), and custom dosage forms, with supporting
development, analytics, stability and regulatory documentation.
The company works worldwide.
Business
Overview:
The output of US chemicals is forecast to grow at an annual compounded
rate of 5.7 percent between 2007 and 2012. Demand is driven by the health of
the US economy because chemicals are used to make a wide variety of industrial
and consumer products. The profitability of individual companies is closely
tied to efficient operations. Big companies have large economies of scale in
production. Small companies can compete effectively by producing specialty
products, of which there are a large number, or by operating a single plant
highly efficiently. The industry is highly automated: average annual revenue
per employee is over $500,000.
The directors of the
company are:
-
H. Barry Robins, President,
-
Anthony Delprete, Executive
Vice President,
-
Brian S Robins, Vice
President,
-
David A Robins, Vice
President,
-
Gifford P Marzoni, Vice President,
-
Mappula S Raju, Vice
President.
They are also the main
shareholders.
Davos Chemical does not publish any
financial statement.
However
our financial sources could provide us with the following information:
|
Fiscal Year In USD |
12/31/2007 |
|
Turnover |
4,300,000 |
|
Operating profit |
540,000 |
|
Net income |
410,000 |
|
Net worth |
600,000 |
|
Liabilities |
100,000 |
0 Suits
0 Judgments
0 Liens
0 Collection Claims
Reported
0 NSF Cheques Reported
0 UCC Security Filings
Date High Credit Now Owing Past Due Terms Payment Record
Local credit bureau gave a correct credit rate.
The Company is in “good standing”.
This means that all local and federal taxes were paid on due date.
-
The cash flow is correct.
-
Payments are made on 35 days nets.
Our final opinion:
This is a small company
working worldwide.
A credit line may be
considered.
|
FINANCIAL SUMMARY |
DEBT COLLECTIONS
AND PAYMENTS |
||
|
PROFITABILITY INDEBTNESS CASH |
Good Controlled Correct |
PUBLIC PAYMENTS |
See Details Above Regular |
150,000 USD
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)